Mack, Gene

Gene Mack joined Imcyse in November 2021 as Chief Financial Officer. He has over 25 years of experience in the life sciences sector, with particular focus on capital markets, business development and corporate finance. Prior to joining Imcyse, Gene was CFO at OncoC4, a privately held biotechnology company that spun out of MSD’s acquisition of OncoImmune. Before that, he has held the CFO role for several development- and commercial-stage biopharmaceutical companies, raising over $150 million in IPO and other equity transactions. Prior to his operational experience, Gene covered the biotechnology and life sciences sector a senior publishing analyst at various investment banks, including Gruntal & Co, Lazard, and HSBC. Gene received his BS in Biochemistry and MBA in Finance from Fordham University.